REDCO HEALTHY (02370) Income Statement & Earnings

1.100
-0.040-3.51%

15min DelayMarket Closed Aug 14 15:14 CST

220.00MMarket Cap-11.34P/E (TTM)

REDCO HEALTHY (02370) Income Statement

Cumulative·All

YOY

Hide blank lines

Currency: CNY

2025/FY

2025/H1

2024/FY

2024/H1

2023/FY

2023/H1

2022/FY

2022/H1

2021/FY

2021/Q9

2021/H1

2020/FY

2020/Q9

2020/H1

2019/FY

2018/FY

Total Revenue

-4.55%400.54M

-1.47%209.01M

-6.60%419.64M

-9.02%212.12M

+2.78%449.27M

+12.19%233.15M

+23.36%437.11M

+19.47%207.81M

+59.89%354.33M

+62.52%260.46M

+63.45%173.94M

+22.59%221.61M

--160.27M

--106.42M

+45.49%180.78M

--124.25M

Operating Revenue

-4.55%400.54M

-1.47%209.01M

-6.60%419.64M

-9.02%212.12M

+2.78%449.27M

+12.19%233.15M

+23.36%437.11M

+19.47%207.81M

+59.89%354.33M

+62.52%260.46M

+63.45%173.94M

+22.59%221.61M

--160.27M

--106.42M

+45.49%180.78M

--124.25M

Cost of Revenue

+0.84%-303.63M

-1.18%-156.76M

+5.38%-306.21M

+4.20%-154.94M

-9.98%-323.60M

-15.56%-161.73M

-23.34%-294.24M

-22.83%-139.96M

-64.74%-238.56M

-69.07%-173.76M

-68.47%-113.94M

-15.97%-144.81M

---102.77M

---67.63M

-27.24%-124.87M

---98.14M

Cost of Goods Sold

+0.84%-303.63M

-1.18%-156.76M

+5.38%-306.21M

+4.20%-154.94M

-9.98%-323.60M

-15.56%-161.73M

-23.34%-294.24M

-22.83%-139.96M

-64.74%-238.56M

-69.07%-173.76M

-68.47%-113.94M

-15.97%-144.81M

---102.77M

---67.63M

-27.24%-124.87M

---98.14M

Gross Profit

-14.57%96.91M

-8.63%52.24M

-9.74%113.43M

-19.94%57.18M

-12.04%125.67M

+5.26%71.42M

+23.41%142.87M

+13.09%67.85M

+50.74%115.77M

+50.80%86.70M

+54.69%60.00M

+37.38%76.80M

--57.50M

--38.79M

+114.10%55.91M

--26.11M

Operating Expense

+19.84%-100.01M

-4.42%-49.81M

-1.41%-124.76M

-12.34%-47.71M

+5.36%-123.02M

+1.19%-42.47M

-109.06%-129.99M

-23.88%-42.98M

-165.61%-62.18M

-222.95%-50.09M

-286.21%-34.69M

-32.61%-23.41M

---15.51M

---8.98M

-50.23%-17.65M

---11.75M

Selling Expenses

+28.78%-2.09M

-28.96%-1.34M

-67.87%-2.94M

-34.20%-1.04M

+33.24%-1.75M

+66.14%-772.00K

+33.38%-2.62M

-16.21%-2.28M

-86.31%-3.93M

-109.73%-3.21M

-125.78%-1.96M

-108.80%-2.11M

---1.53M

---869.00K

---1.01M

----

Administrative Expenses

-25.29%-70.40M

+0.74%-32.62M

+2.93%-56.19M

+1.46%-32.86M

+0.57%-57.89M

+11.55%-33.35M

-6.32%-58.22M

-24.32%-37.71M

-175.75%-54.76M

-230.98%-43.64M

-289.58%-30.33M

-18.15%-19.86M

---13.18M

---7.79M

-40.81%-16.81M

---11.94M

Impairment and Provision

+58.07%-27.52M

-14.85%-15.86M

-3.54%-65.63M

-65.49%-13.81M

+8.33%-63.39M

-178.94%-8.34M

-1883.11%-69.15M

-24.52%-2.99M

-141.98%-3.49M

-307.66%-3.25M

-630.09%-2.40M

-973.33%-1.44M

---796.00K

---329.00K

-10.81%165.00K

--185.00K

-Goodwill Impairment

+75.61%-6.01M

----

---24.65M

----

-Impairment Losses of Other Assets

+47.52%-21.51M

-14.85%-15.86M

+35.35%-40.98M

-65.49%-13.81M

+8.33%-63.39M

-178.94%-8.34M

-1883.11%-69.15M

-24.52%-2.99M

-141.98%-3.49M

-307.66%-3.25M

-630.09%-2.40M

-973.33%-1.44M

---796.00K

---329.00K

-10.81%165.00K

--185.00K

Special Items of Operating Income

+40.94%-1.13M

-55.52%600.00K

-157.81%-1.92M

+257.82%1.35M

+5.93%3.32M

-70.91%377.00K

-20.71%3.14M

-58.55%1.30M

+14.11%3.95M

+281.23%3.90M

+307.16%3.13M

+51.31%3.47M

--1.02M

--768.00K

+184.83%2.29M

--804.00K

Operating Profit

+68.03%-4.24M

-72.00%3.03M

-321.93%-13.25M

-63.11%10.82M

-62.74%5.97M

+12.07%29.33M

-72.16%16.02M

-7.95%26.17M

+1.21%57.54M

-5.81%40.51M

-6.99%28.44M

+40.24%56.86M

--43.01M

--30.57M

+167.34%40.54M

--15.17M

Financing Income

-32.54%827.00K

-23.55%526.00K

+26.13%1.23M

+282.22%688.00K

+249.64%972.00K

-10.89%180.00K

-4.47%278.00K

+21.69%202.00K

+92.72%291.00K

+75.59%223.00K

+118.42%166.00K

-22.56%151.00K

--127.00K

--76.00K

+163.51%195.00K

--74.00K

Financing Cost

+2.62%-966.00K

+6.46%-492.00K

+37.49%-992.00K

+18.95%-526.00K

-20.78%-1.59M

-2.85%-649.00K

-85.33%-1.31M

-116.10%-631.00K

---709.00K

---507.00K

---292.00K

----

Pretax Profit

+62.72%-4.20M

-75.80%2.81M

-262.30%-11.25M

-60.23%11.62M

-56.76%6.93M

+11.03%29.22M

-72.94%16.04M

-8.40%26.32M

+2.33%59.27M

-4.54%41.81M

-7.25%28.73M

+41.93%57.92M

--43.80M

--30.98M

+167.37%40.81M

--15.26M

Special Items of Pretax Income

-89.82%179.00K

-139.56%-252.00K

+11.33%1.76M

+79.94%637.00K

+49.76%1.58M

-38.11%354.00K

-50.82%1.06M

+35.87%572.00K

+134.94%2.15M

+136.99%1.58M

+28.35%421.00K

+1168.06%913.00K

--665.00K

--328.00K

+200.00%72.00K

--24.00K

Adjustment Items of Pretax Income

----

--10.00K

----

Tax

+42.76%-5.06M

+7.23%-3.62M

-32.53%-8.84M

+52.75%-3.90M

-9.58%-6.67M

-1.54%-8.25M

+68.21%-6.08M

+28.92%-8.13M

-37.57%-19.14M

-30.06%-14.28M

-45.03%-11.43M

-26.41%-13.91M

---10.98M

---7.88M

-165.76%-11.01M

---4.14M

Net Profit

+53.94%-9.25M

-110.41%-804.00K

-7624.34%-20.09M

-63.17%7.72M

-97.32%267.00K

+15.26%20.97M

-75.20%9.95M

+5.16%18.19M

-8.81%40.13M

-16.11%27.54M

-25.10%17.30M

+47.66%44.01M

--32.82M

--23.10M

+167.97%29.80M

--11.12M

Profit from Continuing Operations

+53.94%-9.25M

-110.41%-804.00K

-7624.34%-20.09M

-63.17%7.72M

-97.32%267.00K

+15.26%20.97M

-75.20%9.95M

+5.16%18.19M

-8.81%40.13M

-16.11%27.54M

-25.10%17.30M

+47.66%44.01M

--32.82M

--23.10M

+167.97%29.80M

--11.12M

Minority Interests

-0.62%8.29M

-25.74%4.94M

-18.65%8.34M

-9.28%6.65M

+51.54%10.25M

+27.57%7.33M

-15.38%6.76M

+75.40%5.75M

+81.74%7.99M

+133.24%5.27M

+47.63%3.28M

+131.35%4.40M

--2.26M

--2.22M

+254.66%1.90M

--536.00K

Net Income to Parent Company

+38.30%-17.54M

-635.14%-5.74M

-184.76%-28.43M

-92.13%1.07M

-413.04%-9.98M

+9.59%13.64M

-90.08%3.19M

-11.25%12.45M

-18.86%32.14M

-27.15%22.27M

-32.83%14.02M

+41.96%39.61M

--30.56M

--20.88M

+163.58%27.90M

--10.59M

Net Income to Common Stockholders

+38.30%-17.54M

-635.14%-5.74M

-184.76%-28.43M

-92.13%1.07M

-413.04%-9.98M

+9.59%13.64M

-90.08%3.19M

-11.25%12.45M

-18.86%32.14M

-27.15%22.27M

-32.83%14.02M

+41.96%39.61M

--30.56M

--20.88M

+163.58%27.90M

--10.59M

Basic EPS

+38.28%-0.09

-631.48%-0.03

-184.77%-0.14

-92.08%0.01

-393.53%-0.05

-4.08%0.07

-92.07%0.02

-23.96%0.07

-18.86%0.21

-27.14%5.57M

-100.00%0.09

-100.00%0.26

--7.64M

--5.22M

+163.54%6.98M

--2.65M

Diluted EPS

+38.28%-0.09

-631.48%-0.03

-184.77%-0.14

-92.08%0.01

-393.53%-0.05

-4.08%0.07

-92.07%0.02

-23.96%0.07

-18.86%0.21

-27.14%5.57M

-100.00%0.09

-100.00%0.26

--7.64M

--5.22M

+163.54%6.98M

--2.65M

Deadline

Dec 31, 2025

Jun 30, 2025

Dec 31, 2024

Jun 30, 2024

Dec 31, 2023

Jun 30, 2023

Dec 31, 2022

Jun 30, 2022

Dec 31, 2021

Sep 30, 2021

Jun 30, 2021

Dec 31, 2020

Sep 30, 2020

Jun 30, 2020

Dec 31, 2019

Dec 31, 2018

Accounting Standard

HKAS

Audit Opinions

	2025/FY	2025/H1	2024/FY	2024/H1	2023/FY	2023/H1	2022/FY	2022/H1	2021/FY	2021/Q9	2021/H1	2020/FY	2020/Q9	2020/H1	2019/FY	2018/FY

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"